» Articles » PMID: 37698949

Ultrasensitive Detection of Circulating LINE-1 ORF1p As a Specific Multicancer Biomarker

Abstract

Significance: The LINE-1 ORF1p transposon protein is pervasively expressed in many cancers and is a highly specific biomarker of multiple common, lethal carcinomas and their high-risk precursors in tissue and blood. Ultrasensitive ORF1p assays from as little as 25 μL plasma are novel, rapid, cost-effective tools in cancer detection and monitoring. See related commentary by Doucet and Cristofari, p. 2502. This article is featured in Selected Articles from This Issue, p. 2489.

Citing Articles

LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker.

de Santiago P, Sato S, Zhang S, Dougher M, Devins K, Bilecz A NPJ Precis Oncol. 2025; 9(1):62.

PMID: 40050409 PMC: 11885553. DOI: 10.1038/s41698-025-00849-1.


Targeted detection of endogenous LINE-1 proteins and ORF2p interactions.

Nielsen M, Wolters J, Bringas O, Jiang H, Di Stefano L, Oghbaie M Mob DNA. 2025; 16(1):3.

PMID: 39915890 PMC: 11800616. DOI: 10.1186/s13100-024-00339-4.


Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS.

Bedia J, Jacobs I, Ryan A, Gentry-Maharaj A, Burnell M, Singh N EBioMedicine. 2025; 112:105554.

PMID: 39808947 PMC: 11782890. DOI: 10.1016/j.ebiom.2024.105554.


Chromosomal rearrangements and instability caused by the LINE-1 retrotransposon.

Mendez-Dorantes C, Zeng X, Karlow J, Schofield P, Turner S, Kalinowski J bioRxiv. 2025; .

PMID: 39764018 PMC: 11702581. DOI: 10.1101/2024.12.14.628481.


The reconstruction of evolutionary dynamics of processed pseudogenes indicates deep silencing of "retrobiome" in naked mole rat.

Kogan V, Molodtsov I, Fleyshman D, Leontieva O, Koman I, Gudkov A Proc Natl Acad Sci U S A. 2024; 121(45):e2313581121.

PMID: 39467133 PMC: 11551321. DOI: 10.1073/pnas.2313581121.


References
1.
Solyom S, Ewing A, Rahrmann E, Doucet T, Nelson H, Burns M . Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res. 2012; 22(12):2328-38. PMC: 3514663. DOI: 10.1101/gr.145235.112. View

2.
Cohen L, Cui N, Cai Y, Garden P, Li X, Weitz D . Single Molecule Protein Detection with Attomolar Sensitivity Using Droplet Digital Enzyme-Linked Immunosorbent Assay. ACS Nano. 2020; 14(8):9491-9501. DOI: 10.1021/acsnano.0c02378. View

3.
Katz-Summercorn A, Jammula S, Frangou A, Peneva I, ODonovan M, Tripathi M . Multi-omic cross-sectional cohort study of pre-malignant Barrett's esophagus reveals early structural variation and retrotransposon activity. Nat Commun. 2022; 13(1):1407. PMC: 8931005. DOI: 10.1038/s41467-022-28237-4. View

4.
Ignjatovic V, Geyer P, Palaniappan K, Chaaban J, Omenn G, Baker M . Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data. J Proteome Res. 2019; 18(12):4085-4097. PMC: 6898750. DOI: 10.1021/acs.jproteome.9b00503. View

5.
Siegel R, Miller K, Fuchs H, Jemal A . Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33. DOI: 10.3322/caac.21708. View